Get started
Author

Jiarui Zhou

Observed names: J Zhou, Jia-Rui Zhou, Jia-rui Zhou, Jia‐rui Zhou
Observed institutions: Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, First Hospital of Jilin University, Beijing Dao Pei Hospital, State Key Laboratory of Biotherapy, Hebei Yanda Ludaopei Hospital
ORCID: 0009-0006-9563-3557
Observed ORCID: 0009-0006-9563-3557
OpenAlex ID: A5102490883
Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia
2021 · Yan-Li Zhao, De-Yan Liu, et al. · Frontiers in Immunology · 76
PDF
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia
2018 · Yue Lu, Rui-Juan Sun, et al. · Transplantation and Cellular Therapy · 55
PDF
Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant
2023 · Xing-yu Cao, Jian-ping Zhang, et al. · Frontiers in Immunology · 21
Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study
2020 · Yue Lu, Yan-Li Zhao, et al. · Annals of Hematology · 19
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy
2024 · Xing‐yu Cao, Jian‐ping Zhang, et al. · British Journal of Haematology · 16
PDF
Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts
2021 · Yue Lu, Min Xiong, et al. · Hematology · 16
Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status
2020 · Yue Lu, Yan-Li Zhao, et al. · Annals of Hematology · 16
Minocycline/Amoxicillin-Based Bismuth Quadruple Therapy for Helicobacter pylori Eradication: A Pilot Study
2024 · Senlin You, Xiaoqiong Tang, et al. · Microorganisms · 15
PDF
Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
2023 · Yue Lu, Jian-Ping Zhang, et al. · Frontiers in Immunology · 11
PDF
Sustained remission after ruxolitinib and chimeric antigen receptor T‐cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome‐like B‐cell precursor acute lymphoblastic leukemia with novel NPHP3‐JAK2 fusion
2021 · Xue Chen, Lili Yuan, et al. · Genes Chromosomes and Cancer · 8
[HLA- haploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLA- unrelated donor transplantation].
2016 · Yue Lu, Tong Wu, et al. · PubMed Central · 5
PDF
Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study
2022 · Yue Lu, Min Xiong, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Improved Outcomes of Haploidentical Blood and Marrow Transplantation in Hematologic Malignancies: A Single Center Study of 514 Cases
2015 · Yan-Li Zhao, Tong Wu, et al. · Blood · 4
Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant
2020 · Jianping Zhang, Junfang Yang, et al. · Blood · 3
CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia
2018 · Yanli Zhao, Jianping Zhang, et al. · Blood · 3
[Salvaged allogeneic hematopoietic stem cell transplantation for refractory/recurrent acute myeloid leukemia].
2012 · Jing-bo Wang, Tong Wu, et al. · PubMed · 3
A Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL/Lbl Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation
2023 · Xingyu Cao, Jianping Zhang, et al. · Blood · 2
[The efficacy of sorafenib to prevent relapse in patients with FLT3-ITD mutation positive acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
2016 · Y L Zu, Y L Zhang, et al. · PubMed · 2
Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant
2022 · Xing-yu Cao, Jian-Ping Zhang, et al. · Blood · 1
Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for 67 Pediatric Patients with High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL)
2019 · Rui-Juan Sun, Zhi-Jie Wei, et al. · Transplantation and Cellular Therapy · 1
PDF
Haploidentical Hematopoietic Stem Cell Transplantation of Sex-Matched Donor-Recipient Pair Has Survival Advantage: A Single-Center Study of 440 Cases
2010 · Tong Wu, Yan-Li Zhao, et al. · Blood · 1
Prognostic Associations of Molecular MRD and Genomic Features in ZNF384-Rearranged B-ALL Undergoing Allo-HSCT
2026 · Xue-Shuang Zhang, Yan-Li Zhao, et al. · Transplantation and Cellular Therapy
Disease biology rather than donor type determines transplant outcomes in KMT2A-rearranged AML
2026 · Xue-Shuang Zhang, Yan-Li Zhao, et al. · Annals of Hematology
Peritransplant KMT2A-r Molecular MRD Dynamics and Relapse Timing Stratify Outcomes After Allo-HSCT in CR1 Acute Leukemia
2026 · Bai-Qing Sun, Yan-Li Zhao, et al. · Transplantation and Cellular Therapy
Long-Term Outcomes of Second Allogeneic Transplantation Following CD7 CAR-T in Remission for T-Cell Acute Lymphoblastic Leukemia or Lymphoma
2026 · Xing-yu Cao, Jian-ping Zhang, et al. · Transplantation and Cellular Therapy
Works count: 59
Citation count: 282
H-index: 9
I10-index: 9
Year
Topic
Type